FDA Alert
FDA Alert
02/26/2025
Kate Young
The FDA has approved insulin-aspart-szj, an insulin biosimilar for adults and children with diabetes.
02/26/2025
FDA Alert
FDA Alert
07/19/2023
Jessica Ganga
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
07/19/2023